| Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Aug 19 |
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
|
| Aug 12 |
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
|
| Aug 6 |
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
|
| Aug 6 |
Alzamend Neuro partners with Mass General for Alzheimer’s treatment trial
|
| Aug 5 |
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
|
| Jul 31 |
Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
|
| Jul 12 |
Alzamend Neuro approves one-for-ten reverse stock split
|
| Jul 12 |
Alzamend Neuro Announces Reverse Stock Split
|
| Jun 3 |
Alzamend Neuro files to sell 125M shares of common stock for holders
|
